Assistant Professor, Medicine, University of Maryland School of Medicine

Endocrinology

Dr. Kashif Munir, MD


Kashif Munir, MD is an expert in the field of Endocrinology. He attended Temple University School of Medicine. He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Diabetes Recognition Program". Kashif Munir is a published doctor and has 10 publications published. The lastest was: 'A review of dopamine agonist therapy in type 2 diabetes and effects on cardio-metabolic parameters.' Dr. Kashif Munir is registered with Medicare.



Publications


Schools


Procedures Preformed


Conditions Treated


Doctors Specialties


Accepted Insurances


Awards


Education


Hospital


Drug Facts


NPI NUMBER   1063402170
NPPES Provider LastName   MUNIR
NPPES Provider FirstName   KASHIF
NPPES Provider ZIPCode   212011544
NPPES Provider State   MD
Specialty Description   Endocrinology
Total Claim Count   1124.0
Distinct Opioid Count   1.0
Opioid Claim Count   14.0
Percent Opioid Claims   1.25

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1063402170
Last Name Of The Provider MUNIR
First Name Of The Provider KASHIF
View All

Similar Doctors


Dr. Ari S. Eckman, MD
This Doctor is OpenDoctor Recommended.
Dr. Richard B. Horenstein, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Francis Y. Lee, MD
This Doctor is OpenDoctor Recommended.
Dr. Mansur E. Shomali, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Martin L. Binstock, MD
This Doctor is OpenDoctor Recommended.
Dr. Bruce P. Hamilton, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Errol H. Rushovich, MD
This Doctor is OpenDoctor Recommended.
Dr. Mark A. Walker, MD
Dr. Rachel Y. Chong, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Arsalan Sheikh, DO
This Doctor is OpenDoctor Recommended.
Dr. Deepti Bahl, MD
This Doctor is OpenDoctor Recommended.


Doctor Directory | TOS | twitter | FB | Angel | blog